JP2003508517A5 - - Google Patents

Download PDF

Info

Publication number
JP2003508517A5
JP2003508517A5 JP2001521708A JP2001521708A JP2003508517A5 JP 2003508517 A5 JP2003508517 A5 JP 2003508517A5 JP 2001521708 A JP2001521708 A JP 2001521708A JP 2001521708 A JP2001521708 A JP 2001521708A JP 2003508517 A5 JP2003508517 A5 JP 2003508517A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001521708A
Other languages
Japanese (ja)
Other versions
JP4208463B2 (ja
JP2003508517A (ja
Filing date
Publication date
Priority claimed from GBGB9920919.9A external-priority patent/GB9920919D0/en
Application filed filed Critical
Publication of JP2003508517A publication Critical patent/JP2003508517A/ja
Publication of JP2003508517A5 publication Critical patent/JP2003508517A5/ja
Application granted granted Critical
Publication of JP4208463B2 publication Critical patent/JP4208463B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2001521708A 1999-09-03 2000-09-01 キノロンカルボン酸誘導体の製造に関する中間体 Expired - Fee Related JP4208463B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9920919.9 1999-09-03
GBGB9920919.9A GB9920919D0 (en) 1999-09-03 1999-09-03 Novel compound
PCT/GB2000/003358 WO2001017961A2 (en) 1999-09-03 2000-09-01 Intermediates for the production of naphthyridine-3-carboxylic acid derivatives

Publications (3)

Publication Number Publication Date
JP2003508517A JP2003508517A (ja) 2003-03-04
JP2003508517A5 true JP2003508517A5 (https=) 2005-12-22
JP4208463B2 JP4208463B2 (ja) 2009-01-14

Family

ID=10860355

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001521708A Expired - Fee Related JP4208463B2 (ja) 1999-09-03 2000-09-01 キノロンカルボン酸誘導体の製造に関する中間体

Country Status (30)

Country Link
US (3) US6703512B1 (https=)
EP (1) EP1212321B1 (https=)
JP (1) JP4208463B2 (https=)
KR (1) KR100705363B1 (https=)
CN (1) CN1255402C (https=)
AR (1) AR029452A1 (https=)
AT (1) ATE270671T1 (https=)
AU (1) AU773698B2 (https=)
BR (1) BRPI0013750B8 (https=)
CA (1) CA2383751C (https=)
CO (1) CO5180620A1 (https=)
CZ (1) CZ2002759A3 (https=)
DE (1) DE60012028T2 (https=)
DK (1) DK1212321T3 (https=)
ES (1) ES2223570T3 (https=)
GB (1) GB9920919D0 (https=)
HK (1) HK1046908B (https=)
HU (1) HU229391B1 (https=)
IL (2) IL148441A0 (https=)
MX (1) MXPA02002356A (https=)
MY (1) MY126789A (https=)
NO (1) NO322501B1 (https=)
NZ (1) NZ517601A (https=)
PL (1) PL206491B1 (https=)
PT (1) PT1212321E (https=)
SI (1) SI1212321T1 (https=)
TR (1) TR200200548T2 (https=)
TW (1) TWI264435B (https=)
WO (1) WO2001017961A2 (https=)
ZA (1) ZA200201779B (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2281817C (en) * 1999-06-29 2008-07-29 Smithkline Beecham Corporation Methods of use of fluoroquinolone compounds against maxillary sinus pathogenic bacteria
GB9920919D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel compound
GB9920917D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel process
EP1412078B1 (en) 2001-08-02 2008-10-08 LG Life Sciences Limited Processes for the production of amino-protected derivatives of 4-aminomethylene-pyrrolidin-3-one, gemifloxacin or a salt thereof
KR100517638B1 (ko) 2002-04-08 2005-09-28 주식회사 엘지생명과학 게미플록사신 산염의 새로운 제조방법
CN100358949C (zh) * 2002-07-17 2008-01-02 西巴特殊化学品控股有限公司 制备喹吖啶酮颜料的氧化法
KR100653334B1 (ko) * 2003-03-07 2006-12-04 주식회사 엘지생명과학 4-아미노메틸-3-알콕시이미노피롤리딘 메탄설폰산염의 신규한 제조 방법
US8822934B2 (en) * 2006-11-03 2014-09-02 Accuray Incorporated Collimator changer
CN104693088B (zh) * 2013-12-06 2018-01-05 常州市勇毅生物药业有限公司 一种吉米沙星侧链的制备方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57134482A (en) 1981-02-13 1982-08-19 Dainippon Pharmaceut Co Ltd 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8- naphthyridine-3-carboxylic acid-3/2 hydrate and its preparation
IN162769B (https=) 1984-11-13 1988-07-09 Kyorin Seiyaku Kk
NZ222047A (en) 1986-10-08 1991-01-29 Bristol Myers Co Quinoline - or naphthyridine - carboxylic acid anti-bacterial agents
JPH01100165A (ja) 1987-10-13 1989-04-18 Shionogi & Co Ltd オキシムまたはヒドロキシアミン誘導体系抗菌剤
US4920120A (en) 1988-01-25 1990-04-24 Warner-Lambert Company Antibacterial agents
JPH0356479A (ja) 1989-07-24 1991-03-12 Takeshi Yokota 水溶性キノロン誘導体のp‐トルエンスルホン酸塩
IE66202B1 (en) 1989-08-16 1995-12-13 Pfizer Azabicyclo quinolone carboxylic acids
US5137892A (en) 1990-12-12 1992-08-11 Abbott Laboratories Quinoline, naphthyridine and pyridobenzoxazine derivatives
EP0541086A1 (en) 1991-11-08 1993-05-12 Kaken Pharmaceutical Co., Ltd. Antibacterial 6-fluoro-quinolones having an oxime group on the substituent in position 7
JPH0673056A (ja) 1992-08-26 1994-03-15 Kaken Pharmaceut Co Ltd キノリンカルボン酸誘導体およびその塩
US5776944A (en) 1994-06-16 1998-07-07 Lg Chemical Ltd. 7-(4-aminomethyl-3-methyloxyiminopyrroplidin-1-yl)-1-cyclopropyl-6-flu oro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid and the process for the preparation thereof
DK0688772T3 (da) 1994-06-16 1999-11-01 Lg Chemical Ltd Quinolincarboxylsyrederivater med 7-(4-aminomethyl-3-oxim)-pyrrolidinsubstituenter og fremgangsmåde til deres fremstilling
JP3449658B2 (ja) 1994-12-21 2003-09-22 杏林製薬株式会社 安定性に優れた8−アルコキシキノロンカルボン酸水和物並びにその製造方法
US5763454A (en) 1995-06-06 1998-06-09 Pfizer, Inc. Crystal form of anhydrous 7-( 1α,5α,6α!-6-amino-3-azabicyclo 3.1.0!hex-3-yl)-6-fluoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8 naphthyridine-3-carboxylic acid, methanessulfonic acid salt
NZ309134A (en) 1995-08-11 1999-09-29 Pfizer (1s,2s)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1- propranolmethanesulfonate trihydrate
AU726694B2 (en) 1996-03-29 2000-11-16 Smithkline Beecham Corporation Eprosartan dihydrate and a process for its production and formulation
MA24500A1 (fr) * 1997-03-21 1998-10-01 Lg Life Sciences Ltd Derive du sel d'acide carboxylique de naphthyridine .
KR100286874B1 (ko) 1998-03-04 2001-04-16 성재갑 보호된 4-아미노메틸-피롤리딘-3-온의 제조방법
ATE249432T1 (de) 1998-05-29 2003-09-15 Upjohn Co 3-((1'-n-methylamino)ethyl-n-benzyl)pyrrolidin- monomethanesulfonat
GB9820405D0 (en) 1998-09-18 1998-11-11 Smithkline Beecham Plc Process
DK1223935T3 (da) 1999-06-29 2008-02-04 Lg Life Sciences Ltd Anvendelse af gemifloxacinforbindelser mod bakterier
WO2001015695A1 (en) 1999-09-01 2001-03-08 Smithkline Beecham Corporation Methods of use of fluoroquinolone compounds against bacteria
GB9920917D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel process
GB9920919D0 (en) * 1999-09-03 1999-11-10 Sb Pharmco Inc Novel compound
WO2001021176A1 (en) 1999-09-22 2001-03-29 Smithkline Beecham Corporation Methods of use of fluoroquinolone compounds against bacteria
KR20010091379A (ko) 2000-03-15 2001-10-23 성재갑 7-(4-아미노메틸-3-옥심)피롤리딘 치환체를 갖는 퀴놀린카르복실산 유도체의 신규 제조방법
KR20020018560A (ko) 2000-09-01 2002-03-08 성재갑 3-아미노메틸-4-z-메톡시이미노피롤리딘의 신규 제조방법

Similar Documents

Publication Publication Date Title
JP2001222255A5 (https=)
JP2002544307A5 (https=)
JP2003507116A5 (https=)
JP2001073710A5 (https=)
JP2003506176A5 (https=)
JP2001228212A5 (https=)
JP2002174811A5 (https=)
JP2003508517A5 (https=)
JP2001245149A5 (https=)
JP2001206073A5 (https=)
JP2001199465A5 (https=)
JP2001221952A5 (https=)
JP2001325709A5 (https=)
JP2001314487A5 (https=)
JP2001343840A5 (https=)
JP2002197424A5 (https=)
JP2001303422A5 (https=)
JP2001305344A5 (https=)
IN192054B (https=)
IN188280B (https=)
GB0014119D0 (https=)
ECSDI003788S (https=)
ECSDI000606S (https=)
CN3143853S (https=)
CN3139849S (https=)